Netarsudil Brand Name– RHOPRESSA
What is Netarsudil
Netarsudil is a topical Rho kinase inhibitor indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
In clinical studies, up to 5 mmHg reductions in IOP were observed in patients treated with netarsudil ophthalmic solution.
Netarsudil was similar in efficacy to timolol 0.5% for patients with baseline IOP less than 25 mmHg; however, for patients with IOP of 25 mmHg or more, netarsudil resulted in smaller mean IOP reductions at morning time points compared with timolol.
The most common adverse reaction reported in clinical studies with netarsudil was conjunctival hyperemia (53%).
Indications
- glaucoma
- ocular hypertension
For the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension
Side Effects
- blurred vision
- conjunctival hyperemia
- erythema
- lacrimation
- ocular hemorrhage
- ocular pain
Monitoring Parameters
- intraocular pressure
Contraindications
- breast-feeding
- contact lenses
- keratitis
- pregnancy
Interactions
There are no drug interactions associated with Netarsudil products.
